According to GlobalData’s medical device pipeline database, 206 Ultrasound Systems devices are in various stages of development globally. GlobalData’s report Ultrasound Systems provides an overview of the segment’s pipeline landscape and offers detailed analysis of its products. Buy the report here.

Smarter leaders trust GlobalData

Of these devices, 104 are in active development, while the remaining 105 are in an inactive stage of development. There are 57 products in the early stages of development, and the remaining 47 are in the late stages of development.

Ultrasound systems are devices which make use of sound waves of high frequency to produce images of structures inside the body. Most of the devices use sonar principles and are placed outside while in few cases they are even placed inside of the body. 2D ultrasound systems, 3D ultrasound systems, real-time 3D ultrasound systems, and Hand-Held Ultrasound (HHU) systems are tracked under this category. One unit refers to One ultrasound system.

Innovations in the medical devices sector are linked to the development of new approaches, processes, or technologies for treating, diagnosing, and managing disease in response to demand from healthcare for better patient outcomes and reduce healthcare costs.

Based on an analysis of GlobalData’s Medical Intelligence Center pipeline product database, these actively developed Ultrasound Systems pipeline devices are all expected to be approved within the next ten years.

Currently, private organizations, public entities and institutions are working on the development of Ultrasound Systems devices. Overall, most of these Ultrasound Systems pipeline devices are being developed by private entities.

Key players involved in the active development of Ultrasound Systems include Sonivate Medical, Rivanna Medical, Shenzhen Mindray Bio-Medical Electronics, Stanford University, Stanford University, University of California San Diego, ALPINION Medical Systems, Endra, GE HealthCare Technologies and PulseNmore.

For a complete picture of the developmental pipeline for Ultrasound Systems devices, buy the report here.

Data Insights

From

The gold standard of business intelligence.

Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.

GlobalData

GlobalData, the leading provider of industry intelligence, provided the underlying data, research, and analysis used to produce this article. 

The medical devices pipeline data used in this article were obtained from the Medical Pipeline Products Database of GlobalData’s Medical Intelligence Center. The Pipeline Products database is a is a comprehensive source of information on medical devices, it covers 39K products which are in development stage and intended for diagnosis, treatment, and management of diseases/conditions/symptoms directly or indirectly. The pipeline products included in the database are sourced from reliable and authenticated sources, such as company websites, SEC filings, conference presentations, analyst presentations, news releases, clinical trial registries, and grants. The information is collected by following systematic research techniques and proprietary methodology.